Product Information
GS NICOTINE 4 MG MINI LOZENGE is a generic product labeled by L. Perrigo Company, priced at $0.3885 per EA under NDC 00113095702. Its NADAC has been published 378 times since Jul 10, 2019.
FDA first approved this application on Oct 9, 2012.
Strength
4 mg/1
Manufacturer
L. Perrigo CompanyNDC
00113095702
Classification
Generic
Dosage Form
LOZENGE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
NICOTINEApproval Type
Generic (ANDA)
FDA Application
ANDA203690FDA Approved
10/9/2012
On Market Since
4/27/2013
Pharmacological Classes
Price Statistics
The NADAC for GS NICOTINE 4 MG MINI LOZENGE has been published 378 times since Jul 10, 2019, and over the history we have for it it has risen 3.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3885 per EA |
|---|---|
| All-time high | $0.4215 (Jun 10, 2020) |
| All-time low | $0.3337 (May 22, 2024) |
| 52-week high | $0.3906 |
| 52-week low | $0.3568 |
| Median price | $0.3734 |
| Average price | $0.3784 |
| Largest weekly change | +16.5% (Jul 20, 2022) |
| Weeks tracked | 378 |
| Tracking since | Jul 10, 2019 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 11% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
L. Perrigo Company manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Nicotine Polacrilex market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Cholinergic Nicotinic Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of GS NICOTINE 4 MG MINI LOZENGE?
The current National Average Drug Acquisition Cost (NADAC) for GS NICOTINE 4 MG MINI LOZENGE, manufactured by L. Perrigo Company, is $0.3885 per EA (NDC 00113095702), effective Sep 30, 2026.
How has the price of GS NICOTINE 4 MG MINI LOZENGE changed over time?
Over the history we have for it, the NADAC for GS NICOTINE 4 MG MINI LOZENGE has risen 3.5%. It has been tracked across 378 weekly CMS publications since Jul 10, 2019.
What are the highest and lowest recorded NADAC prices for GS NICOTINE 4 MG MINI LOZENGE?
Since Jul 10, 2019, the NADAC for GS NICOTINE 4 MG MINI LOZENGE has ranged from a low of $0.3337 (May 22, 2024) to a high of $0.4215 (Jun 10, 2020), with a median of $0.3734 per EA.
Are there cheaper alternatives to GS NICOTINE 4 MG MINI LOZENGE?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, NICOTINE 4 MG LOZENGE, is $0.3443 per EA — about 11% below GS NICOTINE 4 MG MINI LOZENGE.
Who manufactures GS NICOTINE 4 MG MINI LOZENGE?
GS NICOTINE 4 MG MINI LOZENGE (NDC 00113095702) is labeled by L. Perrigo Company, and CMS classifies it as a generic product.